SALE ON NOW! PROMOTIONS
Martin Stenfeldt (M.Sc. B.A. & Econ.) is a seasoned Danish life science entrepreneur and executive with a deep understanding of the challenges and opportunities involved in scaling life science ventures. As the co-founder and former CEO of MedTrace Pharma A/S, he led the company's evolution from a startup to an international player, guiding its growth from early-stage development to Phase III clinical trials. Under his leadership, MedTrace expanded beyond its headquarters in Denmark, establishing offices in the United States and Sweden, showcasing Martin's ability to navigate the complexities of scaling across diverse markets and regulatory environments.With a comprehensive life science and entrepreneurial network across Scandinavia and the US, Martin offers a global perspective on the industry. His extensive commercial experience, gained through international roles with responsibilities and postings in the US and Germany, has equipped him with invaluable insights into the nuances of life science commercialization on a global scale. Martin's role as a Resident Industry Fellow at the Technical University of Denmark further solidifies his position as a thought leader in life sciences, enabling him to contribute to the development of innovative solutions and mentor the next generation of industry talent. In addition to his fellowship, he has held multiple board positions and actively mentors emerging startups, sharing his expertise in scaling, commercialization, and sustainable growth.
""Scaling Life Sciences"" is essential for anyone looking to transforming research into impact. As the founder of a science-based company, I have experienced the complexities of scaling first-hand. This book distills invaluable insights from over 150 practitioners into practical frameworks, providing a structured approach. It will be a valued guide for researchers, students, and entrepreneurs who seek to understand and navigate the scaleup process in life sciences."" - Anders Bjarklev, Professor, President, The Technical University of Denmark ""Scaling a life science company is a unique and difficult challenge. Martin Stenfeldt's book, based on first hand experience, provides critical and actionable guidance for life science executives and startups with a need for scaling the company's activities. A must-read for any management team planning for scaling towards growth."" - Mads Krogsgaard Thomsen, Chief Executive Officer, Professor, DVM, PhD, DSc, Novo Holdings A/S ""Having scaled Neola Medical in the complex life sciences sector, I can confirm the immense value of Martin's practical insights. His book provides actionable strategies for scaleup leaders, and I'll be recommending it to my network both in Europe and the U.S."" - Hanna Sjöström, CEO Neola Medical ""This book's significance lies in its many real-world examples from scaling companies, illustrating how challenges are either resolved or lead to failure. It offers invaluable insights and inspiration for management teams, boards, and investors, along with practical tools for navigating the complexities of scaling high-potential life science ventures"" - Lene Gerlach, PhD, Venture Partner, Hadean Ventures, Founder and Chairperson WiLD ""Few books tackle scaling like this one. It's a critical resource for board members and executives driving sustainable growth in life sciences."" - Jodi Hubler, Board Chair and Managing Director
The Great River
The Making and Unmaking of the Mississippi...
Paperback
$32.95
Not in-store but you can order this
